The present invention relates to primary CNS tumors and provides useful compositions
and methods for reducing tumor volume and increasing the length of survival in
mammals with primary CNS tumors, thereby providing a treatment for primary CNS
tumors. The invention also relates to methods of identifying compounds for reducing
tumor volume and increasing animal survival, which therefore relate to treating
primary CNS tumors.
